Ernexa Therapeutics Inc. (ERNA) Net margin 2016–2025
Ernexa Therapeutics Inc. (ERNA) net profit margin by fiscal year — reported net income divided by reported revenue.
-2419.9%FY2025 · since FY2016: -11.9% → -2419.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -2419.9% | +63078.6 pp |
| FY2024 | -65498.5% | — |
| FY2021 | -2112.8% | -2076.0 pp |
| FY2020 | -36.8% | -28.0 pp |
| FY2019 | -8.8% | -7.6 pp |
| FY2018 | -1.2% | +3.6 pp |
| FY2017 | -4.8% | +7.1 pp |
| FY2016 | -11.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice